No Image
Polyclonal Antibodies
Anti-CD168/RHAMM Rabbit Polyclonal Antibody (KO Validated) for WB, IF, ELISA - O75330
Item Number : CM0017041
Price varies based on specs and customizations
- Application
- WB, IF/ICC, ELISA
- Cross Reactivity
- Human
- Protein Weight
- 84kDa
Shipping:
Contact us to get shipping details Enjoy On-time Dispatch Guarantee.
Why Choose Us
Easy ordering process, quality products, and dedicated support for your business success.
Core Product Specifications and Parameters
| Parameter | Value |
|---|---|
| Product Name | [KO Validated] CD168/RHAMM Rabbit pAb |
| Remarks/Alias | CD168; IHABP; RHAMM; MM |
| Species | Human |
| Gene ID (Human) | 3161 |
| Gene ID | 3161 |
| Immunogen | Recombinant fusion protein containing a sequence corresponding to amino acids 1-300 of human CD168/RHAMM (NP_001136028.1) |
| Source | Rabbit |
| Category | Polyclonal Antibodies |
| Application | WB, IF/ICC, ELISA |
| Cross Reactivity | Human |
| SWISS | O75330 |
| Protein Weight | 84kDa |
| Shipping | Ice bag |
Biological Background: CD168/RHAMM Function and Localization
- CD168/RHAMM (HMMR) is a receptor for hyaluronic acid (HA) that mediates HA-dependent cell motility and focal adhesion kinase (PTK2/FAK1) phosphorylation.
- The protein contributes to cellular transformation, metastasis formation, and regulation of extracellular-regulated kinase (ERK) signaling.
- HMMR undergoes alternative splicing and contains repetitive sequence motifs; it is classified as a glycoprotein and phosphoprotein.
- Localized at the cell surface, within the cytoplasm, and associates with the mitotic spindle, implicating roles in cell division and motility.
- Expressed in testis and breast tissue, with potential involvement in reproductive biology and breast cancer.
Related references: PMID:22965910 PMID:8890751 - The predicted molecular weight is approximately 84 kDa, consistent with the observed protein weight.
- Hyaluronan binding may trigger signaling pathways involved in adipogenesis and cellular differentiation (By similarity).
Experimental Guidance and Technical Tips
- This antibody targets the N-terminal region (amino acids 1–300) of human CD168/RHAMM; assess epitope accessibility if using truncated or modified proteins.
- For Western blotting, anticipate a band near 84 kDa; validate with positive control lysates from testis or breast cancer cell lines expressing CD168.
- In immunofluorescence, expect cytoplasmic and spindle-associated staining; co-stain with a mitotic marker (e.g., phospho-histone H3) to confirm localization.
- The antibody has been knockout (KO) validated by the supplier; confirm specificity in your system using KO or knockdown controls.
CamelBio: Your One-Stop Sourcing Bridge
CamelBio provides diagnostic manufacturers, labs, and research institutes with end-to-end access to IVD raw materials. This anti-CD168/RHAMM polyclonal antibody supports investigations into cancer metastasis and cell motility, and CamelBio's sourcing network can supply additional validated antibody pairs, optimized monoclonal/polyclonal antibodies, bulk ancillary reagents, and rare-target raw materials to accelerate your assay development.
Product Datasheet
Anti-CD168/RHAMM Rabbit Polyclonal Antibody (KO Validated) for WB, IF, ELISA - O75330
REQUEST A QUOTE
Our professional team will reply to you within one business day. Please feel free to contact us!